PLoS ONE (Jan 2021)

COVID-19 symptoms at time of testing and association with positivity among outpatients tested for SARS-CoV-2

  • David A. Wohl,
  • Amir H. Barzin,
  • Sonia Napravnik,
  • Thibaut Davy-Mendez,
  • Jason R. Smedberg,
  • Cecilia M. Thompson,
  • Laura Ruegsegger,
  • Matt Gilleskie,
  • David J. Weber,
  • Herbert C. Whinna,
  • Melissa B. Miller

Journal volume & issue
Vol. 16, no. 12

Abstract

Read online

Introduction Symptoms associated with SARS-CoV-2 infection remain incompletely understood, especially among ambulatory, non-hospitalized individuals. With host factors, symptoms predictive of SARS-CoV-2 could be used to guide testing and intervention strategies. Methods Between March 16 and September 3, 2020, we examined the characteristics and symptoms reported by individuals presenting to a large outpatient testing program in the Southeastern US for nasopharyngeal SARS-CoV-2 RNA RT-PCR testing. Using self-reported symptoms, demographic characteristics, and exposure and travel histories, we identified the variables associated with testing positive using modified Poisson regression. Results Among 20,177 tested individuals, the proportion positive was 9.4% (95% CI, 9.0–9.8) and was higher for men, younger individuals, and racial/ethnic minorities (all PConclusions In a large outpatient population in the Southeastern US, several symptoms, most notably loss of taste or smell, and greater symptom burden were associated with detection of SARS-CoV-2 RNA. Persons of color and those with who were a contact of a COVID-19 case were also more likely to test positive. These findings suggest that, given limited SARS-CoV-2 testing capacity, symptom presentation and host characteristics can be used to guide testing and intervention prioritization.